We have shown that expression of PR-B containing the PPD inhibited EGF-induced NSCLC cell proliferation both in the presence and absence of progestin, suggesting that expression of the PR-PPD suppressed cytoplasmic/membrane signaling through interfering with the EGFR signaling pathway [24]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.